Literature DB >> 15866121

Differences in invasive capacity of endometrial cancer cell lines expressing different progesterone receptor isotypes: possible involvement of cadherins.

Eline E Hanekamp1, Susanne C J P Gielen, Petra E De Ruiter, Savi Chadha-Ajwani, Frans J Huikeshoven, Curt W Burger, J Anton Grootegoed, Leen J Blok.   

Abstract

OBJECTIVE: Loss of expression of progesterone receptors (PR) in endometrial cancer is related to a more invasive and metastatic phenotype. In this study we aim to investigate whether selective loss of PRA or PRB affects the invasive capacity of endometrial cancer cells.
METHODS: cDNA microarrays were performed to compare gene expression profiles of a set of endometrial cancer sub-cell lines expressing PRA and/or PRB. In vitro invasion assays were performed to assess whether differences in gene expression between the lines were reflected by their invasive behavior.
RESULTS: It was observed that cell lines that express only PRA express higher levels of cadherins, and show a lower level of invasion compared to cell lines that express PRB. When cadherin function was inhibited in exclusively PRA-expressing cell lines, an increase of in vitro invasion was observed. In support of these findings, it was observed that in higher grade and more invasive endometrial cancer, expression of E-cadherin decreased.
CONCLUSIONS: These results indicate that relative loss of PRA during progression of endometrial cancer can have a negative impact on cadherin expression, which may lead to development of a more metastatic phenotype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15866121     DOI: 10.1016/j.jsgi.2005.01.030

Source DB:  PubMed          Journal:  J Soc Gynecol Investig        ISSN: 1071-5576


  5 in total

1.  Endometrial miR-181a and miR-98 expression is altered during transition from normal into cancerous state and target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3.

Authors:  Harekrushna Panda; Tsai-Der Chuang; Xiaoping Luo; Nasser Chegini
Journal:  J Clin Endocrinol Metab       Date:  2012-04-06       Impact factor: 5.958

Review 2.  The EMT signaling pathways in endometrial carcinoma.

Authors:  Eva Colas; Nuria Pedrola; Laura Devis; Tugçe Ertekin; Irene Campoy; Elena Martínez; Marta Llauradó; Marina Rigau; Mireia Olivan; Marta Garcia; Silvia Cabrera; Antonio Gil-Moreno; Jordi Xercavins; Josep Castellvi; Angel Garcia; Santiago Ramon y Cajal; Gema Moreno-Bueno; Xavier Dolcet; Francesc Alameda; Jose Palacios; Jaime Prat; Andreas Doll; Xavier Matias-Guiu; Miguel Abal; Jaume Reventos
Journal:  Clin Transl Oncol       Date:  2012-08-22       Impact factor: 3.405

3.  Association between Morphological Patterns of Myometrial Invasion and Cancer Stem Cell Markers in Endometrial Endometrioid Carcinoma.

Authors:  Ji Y Park; Daegy Hong; Ji Young Park
Journal:  Pathol Oncol Res       Date:  2017-10-08       Impact factor: 3.201

Review 4.  Molecular determinants of invasion in endometrial cancer.

Authors:  M Abal; M Llauradó; A Doll; M Monge; E Colas; M González; M Rigau; H Alazzouzi; S Demajo; J Castellví; A García; S Ramón y Cajal; J Xercavins; M H Vázquez-Levin; F Alameda; A Gil-Moreno; J Reventos
Journal:  Clin Transl Oncol       Date:  2007-05       Impact factor: 3.405

5.  Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.

Authors:  Paul H van der Horst; Yongyi Wang; Ingrid Vandenput; Liesbeth C Kühne; Patricia C Ewing; Wilfred F J van Ijcken; Marten van der Zee; Frederic Amant; Curt W Burger; Leen J Blok
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.